SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001415889-20-000201
Filing Date
2020-01-31
Accepted
2020-01-31 17:26:55
Documents
2
Period of Report
2020-01-30

Document Format Files

Seq Description Document Type Size
1 form4-01312020_020141.html 4  
1 form4-01312020_020141.xml 4 7598
2 ex24-01312020_020143.htm EX-24 6584
  Complete submission text file 0001415889-20-000201.txt   15818
Mailing Address 950 WINTER STREET WALTHAM MA 02451
Business Address 950 WINTER STREET WALTHAM MA 02451 (858) 909-0749
Eloxx Pharmaceuticals, Inc. (Issuer) CIK: 0001035354 (see all company filings)

IRS No.: 841368850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 8731 Services-Commercial Physical & Biological Research
Office of Trade & Services

Mailing Address 185 BERRY STREET SUITE 6504 SAN FRANCISCO CA 94107
Business Address
WEAVER GREGORY L (Reporting) CIK: 0001251779 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-31326 | Film No.: 20566140